SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-20-000216
Filing Date
2020-08-04
Accepted
2020-08-04 08:33:02
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-630202010xq.htm 10-Q 1098051
2 EXHIBIT 31.1 evfm-6302020ex311.htm EX-31.1 21663
3 EXHIBIT 31.2 evfm-6302020ex312.htm EX-31.2 21901
4 EXHIBIT 32.1 evfm-6302020ex321.htm EX-32.1 13249
  Complete submission text file 0001618835-20-000216.txt   7059155

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT evfm-20200630.xml EX-101.INS 1422875
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20200630.xsd EX-101.SCH 60006
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20200630_cal.xml EX-101.CAL 73533
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20200630_def.xml EX-101.DEF 338258
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20200630_lab.xml EX-101.LAB 741904
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20200630_pre.xml EX-101.PRE 457598
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 201071044
SIC: 2834 Pharmaceutical Preparations